I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 18 studies | 23% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 14 studies | 25% ± 6% | |
| epithelial cell | 6 studies | 31% ± 13% | |
| ciliated cell | 4 studies | 25% ± 5% | |
| respiratory goblet cell | 4 studies | 29% ± 5% | |
| endothelial cell | 4 studies | 29% ± 13% | |
| club cell | 4 studies | 24% ± 5% | |
| astrocyte | 4 studies | 27% ± 6% | |
| glutamatergic neuron | 4 studies | 45% ± 16% | |
| interneuron | 4 studies | 35% ± 19% | |
| oligodendrocyte | 4 studies | 23% ± 3% | |
| basal cell | 3 studies | 25% ± 9% | |
| GABAergic neuron | 3 studies | 46% ± 6% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 6% | |
| type I pneumocyte | 3 studies | 20% ± 4% | |
| goblet cell | 3 studies | 37% ± 24% | |
| transit amplifying cell | 3 studies | 26% ± 13% |
